| Phase 13 trials |
|
Phase 1
|
NCT05028946 |
May 2022 → Jul 2023 |
Crohn disease |
Tiziana Life Sciences LTD |
Withdrawn
|
No outcome recorded
|
|
Phase 1
|
NCT05029609 |
Oct 2021 → Nov 2022 |
primary progressive multiple sclerosis, secondary progressive multiple sclerosis |
Tiziana Life Sciences LTD |
Withdrawn
|
No outcome recorded
|
|
Phase 1
|
NCT06879067 |
Nov 2018 → Jul 2019 |
— |
Tiziana Life Sciences LTD |
Completed
|
No outcome recorded
|
| Phase 1/22 trials |
|
Phase 1/2
|
NCT00805909 |
Aug 2007 → Jan 2009 |
acute transplant rejection |
Light Chain Bioscience - Novimmune SA |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT00630643 |
Jan 2006 → Dec 2007 |
Crohn disease |
Light Chain Bioscience - Novimmune SA |
Completed
|
No outcome recorded
|
| Phase 26 trials |
|
Phase 2
|
NCT07688239 |
Jul 2026 → Jul 2027 expected |
amyotrophic lateral sclerosis |
Tiziana Life Sciences LTD |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06868628 |
May 2025 → Apr 2027 expected |
multiple system atrophy |
Tiziana Life Sciences LTD |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06890923 |
Mar 2025 → Apr 2026 overdue |
secondary progressive multiple sclerosis |
Tiziana Life Sciences LTD |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06292923 |
Nov 2023 → Sep 2026 expected |
secondary progressive multiple sclerosis |
Tiziana Life Sciences LTD |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT04983446 |
Apr → Oct 2022 |
COVID-19 |
Tiziana Life Sciences LTD |
Withdrawn
|
No outcome recorded
|
|
Phase 2
|
NCT03291249 |
Dec 2017 → Dec 2018 |
metabolic dysfunction-associated steatohepatitis, type 2 diabetes mellitus |
Tiziana Life Sciences LTD |
Withdrawn
|
No outcome recorded
|
| Phase not stated1 trial |
| — |
NCT06802328 |
— |
secondary progressive multiple sclerosis |
Tiziana Life Sciences LTD |
Available
|
No outcome recorded
|